HCA buys urgent care chain in Florida
HCA continues to double down on the Florida market where it has invested $3 billion over the last three years.
Roche, Siemens at-home tests get FDA EUAs as US faces COVID-19 testing shortage
The agency granted emergency use authorizations to both companies’ over-the-counter diagnostics under a new accelerated review program. However, it may take months for them to scale up production.
Supreme Court sets Jan. 7 hearing on vaccine mandate rules
The justices will hear arguments on the requirement that healthcare workers must be fully vaccinated, amid a flurry of legal challenges.
Tenet completes $1B surgery center acquisition
This is the second billion-dollar deal with SurgCenter Development in as many years as Tenet continues building out its surgery center footprint, a key component of its long-term strategy.
J&J device chief on company split, omicron surge, robotic surgery
Ashley McEvoy is confident that 2022 will not be as bad as the first or second year of the COVID-19 pandemic, even as the omicron variant drives cases up, but adds that “we’re not out of the woods yet.”
COVID-19 pill from Pfizer authorized by FDA in major pandemic milestone
Paxlovid is the first oral treatment for COVID-19, a potentially valuable new tool as the fast-spreading omicron variant fuels a sharp surge in cases across the U.S.
After intense pushback, Biogen to cut price of Alzheimer’s drug
Effective Jan. 1, the average list price for Aduhelm will drop about 50% to just over $28,000 a year. It’s a move the company hopes will appease insurers and lower out-of-pocket costs for patients.
For the first time in 25 years, Centene looks for new CEO
Soon, the payer will begin searching for Michael Neidorff’s successor, kicking off an executive search for the first time since he was installed in 1996.
SCOTUS upholds another state vaccine mandate
The high court blocked a challenge to New Mexico’s statewide vaccine mandate for healthcare workers Tuesday. The CMS vaccine mandate remains in place, though injunctions in some states still stand.
Most COVID-19 medical device EUAs lack documented supporting data, JAMA study shows
The use of “low-quality data” is reasonable at the start of a crisis but FDA should consider raising the standard of evidence after multiple products come to market, according to the authors of the study.